Instant Anti Aging Wrinkle Eye Treatment Syringe Cream
NDC Package 87036-034-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Instant Anti Aging Wrinkle Eye Treatment Syringe (acetyl hexapeptide-8) cream is uses:Anti-Wrinkle Correction & Prevention – Formulated through rigorous scientific research and clinical testing, this advanced cream is designed to address the most common concerns of deep lines and wrinkles in the targeted area: wrinkles, fine lines, puffiness, and dark circles. This formulation utilizes a cream delivery system. Marketed by Guangzhou Meijiao Medical Biotechnology Co., Ltd., this product is identified by NDC 87036-034 and is authorized under FDA application 505G(a)(3).

Identification & Billing

NDC Package Code
87036-034-01
Package Description
30 g in 1 SYRINGE, PLASTIC
Product Code
87036-034
11-Digit Billing Format
87036003401

Clinical Specifications

Proprietary Name
Instant Anti Aging Wrinkle Eye Treatment Syringe
Non-Proprietary Name
Acetyl Hexapeptide-8
Substance Name
Acetyl Hexapeptide-8; Dipeptide-2; Hyaluronic Acid; Palmitoyl Tetrapeptide-7; Retinol
Dosage Form
Cream - An emulsion, semisolid3 dosage form, usually containing > 20% water and volatiles5 and/or < 50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route
  • Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
  • Transdermal - Administration through the dermal layer of the skin to the systemic circulation by diffusion.
Active Ingredient(s)
Usage Information
Uses:Anti-Wrinkle Correction & Prevention – Formulated through rigorous scientific research and clinical testing, this advanced cream is designed to address the most common concerns of deep lines and wrinkles in the targeted area: wrinkles, fine lines, puffiness, and dark circles. Using a combination of high-performance ingredients—Hyaluronic Acid, Retinol, Stem Cells, and Peptides—this treatment provides an effective solution for visibly healthier, younger-looking skin.

Regulatory & Marketing

Labeler Name
Guangzhou Meijiao Medical Biotechnology Co., Ltd.
Product Type
Human Otc Drug
FDA Application #
505G(a)(3)
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
11-18-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 87036-034-01 identifies a specific commercial package of 30 g in 1 syringe, plastic of Instant Anti Aging Wrinkle Eye Treatment Syringe, a human over the counter drug labeled by Guangzhou Meijiao Medical Biotechnology Co., Ltd.. This cream is formulated for topical; transdermal use and contains acetyl hexapeptide-8; dipeptide-2; hyaluronic acid; palmitoyl tetrapeptide-7; retinol as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Guangzhou Meijiao Medical Biotechnology Co., Ltd. on November 18, 2025. The current certification is valid through December 31, 2026.

How is this Guangzhou Meijiao Medical Biotechnology Co., Ltd. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 87036003401. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
87036-034-01
11-Digit CMS (5-4-2)
87036-0034-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.